The new Eurosurveillance website is almost here.

Eurosurveillance is on the updated list of the Directory of Open Access Journals and in the SHERPA/RoMEO database. Read more here.

On 6 June 2017, the World Health Organization (WHO) published updates to its ‘Essential Medicines List’ (EML). Read more here.

Follow Eurosurveillance on Twitter: @Eurosurveillanc

In this issue

Home Eurosurveillance Edition  2010: Volume 15/ Issue 22 Article 3
Back to Table of Contents
Previous Download (pdf)

Eurosurveillance, Volume 15, Issue 22, 03 June 2010
Surveillance and outbreak reports
Nationwide outbreak of Salmonella serotype Kedougou associated with infant formula, Spain, 2008
  1. Spanish Field Epidemiology Training Programme (PEAC), National Centre of Epidemiology – Instituto de Salud Carlos III, Madrid, Spain
  2. National Centre of Microbiology, Instituto de Salud Carlos III, Madrid, Spain
  3. National Centre of Epidemiology, Instituto de Salud Carlos III, Madrid, Spain
  4. Biomedical Research Center Network of Epidemiology and Public Health (Centro de Investigación Biomédica en Red, CIBERESP), Barcelona, Spain
  5. Spanish Regional Epidemiology Services and Microbiology laboratories, Spain

Citation style for this article: Rodríguez-Urrego J, Herrera-León S, Echeita-Sarriondia A, Soler P, Simon F, Mateo S, Investigation team. Nationwide outbreak of Salmonella serotype Kedougou associated with infant formula, Spain, 2008. Euro Surveill. 2010;15(22):pii=19582. Available online:
Date of submission: 05 August 2009

On 5 August 2008, the National Centre of Microbiology in Madrid, Spain, notified an increase in Salmonella Kedougou isolations compared to 2007, with 21 cases including 19 children under one year of age. Active case finding and a matched case-control study were carried out to confirm this increase, identify source, transmission mode and risk factors in order to implement control measures. Cases were defined as any child under one year of age with S. Kedougou isolated since 1 January 2008, and were matched for age, sex, medical practitioner and diagnosis week with controls who were selected among patients of the cases' medical practitioners. An ad hoc questionnaire was completed for cases and controls and a univariate analysis was conducted to identify risk factors. We found 42 isolates from 11 of the 19 Spanish Regions. Completed questionnaires were available for 39 of 42 patients identified; 31 were children under one year of age and fulfilled the case definition. The median age of the 31 cases was 4.3 months and 13 were male. Main symptoms were diarrhoea (n=31) and fever (n=13). Ten cases required hospitalisation. All 31 cases had consumed infant formula milk of Brand A which was associated with illness in the univariate analysis (exact matched odds ratio: 74.92; 95% confidence interval: 12.89-∞). All patient isolates showed indistinguishable pulsed-field gel electrophoresis and antimicrobial susceptibility patterns. Five milk samples from three cases' households were negative for Salmonella. Our results suggest that Brand A was the transmission vehicle of S. Kedougou in the outbreak that occurred in Spain between January and August 2008. Food safety authorities recalled five batches of Brand A milk on 26 August 2008. No further cases have been detected as of 15 September 2009.


Salmonella Kedougou belongs to serogroup G Salmonella and is one of the nearly 2,000 Salmonella serotypes that can cause illness in humans, but it is a rare serotype identified in Spain. The National Centre of Microbiology (NCM) in Madrid isolated a mean of three S. Kedougou strains from humans per year between 2002 and 2007 (unpublished data). We only found two outbreaks involving this serotype in the literature: one in Norway in 2006 linked to consumption of Salami [1] and one in the United Kingdom in 1992 linked to cooked meat [2].

On 5 August 2008, the NCM notified an increase in number of S. Kedougou isolates during the first half of 2008: 21 isolates from seven Spanish regions, compared to six isolates in 2007 and two in 2006. Nineteen of these 21 isolates were from children under one year of age. The widespread distribution and the cases’ age suggested a commercial infant food product as the likely vehicle of transmission in this Salmonella outbreak.

On 6 August 2008, the National Centre of Epidemiology (NCE) in collaboration with NCM, regional epidemiologists and microbiologists of the Spanish epidemiological surveillance network began an epidemiological study and sent an alert to the Spanish Food Safety and Nutrition Agency (SFSNA) and to the Ministry of Health. The alert was also sent to the European Food and Waterborne Diseases Network, asking for S. Kedougou increases during 2008. Eleven member countries answered but did not report any increase in S. Kedougou isolates. 

The objectives of our study were to confirm the increase in number of cases and to identify the source of infection, the transmission mode and associated risk factors in order to implement appropriate control measures.

Materials and methods

Epidemiological investigation
An active case finding and a matched case-control study were conducted by the NCE in collaboration with NCM and regional and local epidemiologists to test the hypothesis that consumption of commercial infant food product was associated with the illness.

Active Case Finding
An outbreak case was defined as any person with an isolate of S. Kedougou identified during 2008. NCE sent a request to all regions in Spain through the Spanish Epidemiological Surveillance Network, to notify any case from whom Salmonella Group G was isolated in 2008.

We collected information on the cases with confirmed S. Kedougou infection using a structured questionnaire. They were filled in by regional and local epidemiologists in interviews with the cases or their parents. We asked for demographic information (age, sex, place of residence), clinical information (date of onset, main symptoms, severity, hospitalisation) microbiological information, human and/or animal contact, food consumed in the 72 hours before the onset of symptoms (including brands and batch numbers of infant food consumed), and information about the way of preparation and disinfection as well as the time from preparation to consumption.

The epidemiological data and food history of the first identified cases (see below) raised the hypothesis that consumption of infant formula could be the cause of infection and we started an analytical study.

Analytical study
A case was defined as any child under one year of age with S. Kedougou isolated between 1 January 2008 and 31 August 2008. For each case, four controls were selected and matched for age (±one month), sex, same medical practitioner and week of diagnosis (±one week), without gastrointestinal symptoms and non-exclusive breastfeeding. The same questionnaire was applied to cases and controls, asking for information on their food intake during the three days previous to the onset of symptoms of the case.

Statistical analysis
Odds ratios (OR) and their 95% confidence intervals (CI) for the association between risk factors and disease were estimated using exact conditional logistic regression [3]. Maximum likelihood estimates (MLE) were applied when possible, and median unbiased estimates (MUE) when MLE could not be calculated. All analyses were carried out using STATA 10.0 [4-5].

Microbiological Investigation
Strains isolated from cases at regional hospital laboratories were sent to NCM for serotyping, and comparison of pulsed-field electrophoresis (PFGE) profiles and susceptibility patterns. The strains were tested for susceptibility to ampicillin, cefalotin, cefotaxime, amoxicillin/clavulanic acid, chloramphenicol, gentamicin, kanamycin, nalidixic acid, ciprofloxacin, tetracycline and trimethoprim/sulfamethoxazole.

Samples of infant foods (opened or unopened) provided by cases’ households were also collected and sent to the laboratory of the SFSNA and to the regional laboratories for Salmonella testing.


A total of 42 isolates from 42 patients were identified from January to August 2008. Sixteen patients were male and 32 were children under one year of age. Ten children under one year of age and a pregnant woman required hospitalisation. Patients were from 11 of the 19 regions in Spain (Figure 1).

Figure 1. Cases of Salmonella Kedougou by region, Spain 2008 (N=42)       

The first isolate of S. Kedougou was identified on 4 February 2008 and the last one on 29 August 2008 (Figure 2).

Figure 2. Cases of Salmonella Kedougou by week of isolation and age, Spain, 2008 (N=42)


Questionnaires for the children were answered by the parents. Completed questionnaires were available for 39 of 42 patients identified. For further analysis, we only considered cases under the age of one year. These were 31 of the 39 respondents, with a median age of 4.3 months, and 13 were male. Main symptoms were diarrhoea (n=31), fever (n=13) and vomiting (n=7). Blood was present in the stools of 20 of the patients. Ten children were hospitalised; none of them had a history of immunosuppression.

Five children had a mixed diet (breast feeding and infant formula) and 26 used infant formula exclusively. All the infants had consumed the same milk, Brand A, in the 72 hours before the onset of symptoms. Table 1 shows products consumed by the patients in the 72 hours before onset of symptoms, as well as other exposures.

Table 1. Distribution of exposures during the 72 hours before onset of symptoms in children under one year of age with isolation of Salmonella Kedougou, Spain, 2008 (N=31)

The eight patients over one year of age, for whom a completed questionnaire was available, had a median age of 28 years (range: 1-84 years of age). Two patients were parents of cases under one year of age. Three patients had consumed powder infant formula of Brand A in the 72 hours before the onset of symptoms.

We included 22 cases and 70 controls in the matched case-control study (12 cases were matched with four controls, two cases with three controls and eight cases with two controls).

All cases included in this analytical study consumed infant formula of Brand A in the 72 hours before onset of symptoms compared with seven (10%) of the controls. Because all cases consumed an infant formula of Brand A, the maximum likelihood estimation for the OR of association with illness was infinite. The median unbiased estimate for the Mantel-Haenszel OR (ORM-H) and the lower limit of the CI were thus calculated (exact ORM-H: 74.92; 95% CI: 12,89–∞). Other food products, food preparation, or preservation and disinfection habits were not associated with the disease (Table 2).

Table 2. Matched univariate analysis between Salmonella Kedougou infection and different exposures, Spain, 2008


Antimicrobial susceptibility tests and PFGE were done on all the strains. All PFGE pattern were indistinguishable (SAL-XBA-KDG-1) and all strains had the same sensitivity profile to all antibiotics tested.

We tested five samples of milk consumed before the occurrence of symptoms and provided by three cases’ families. Salmonella was not detected in any of them. No further cases' families were able to provide the batch number of the product consumed.

The infant formula Brand A distributed in Spain up to the day of the study had been produced in a local production plant. The company had closed this production plant in March 2008, five months before the outbreak alert. The results of factory quality control tests provided by the producers from raw materials and incriminated end products were negative for Salmonella, but positive for Enterobacteriaceae in some batches of end product.

On 26 August, the Spanish food safety authorities recalled five batches of infant formula of Brand A. This product was distributed only in Spain. A press release was issued informing people to avoid the use of these batches of milk Brand A and a contact telephone helpline was set up to provide information to consumers.


Our results suggest that the consumption of an infant formula of Brand A was associated with S. Kedougou infection. In our analytical study, 100% of the cases had consumed this milk compared with only 10% of the controls.

Outbreaks associated with infant powder formula are not uncommon because this is not a sterile product. This type of feeding is now usual because of many reasons such as the increased survival of premature babies and newborns with low birth weight, maternal illnesses in which breastfeeding is not recommended, early return of women to work after giving birth, or difficulties in breastfeeding [6].

We are not aware of any outbreak of S. Kedougou associated with infant formula. However, other serotypes of Salmonella had been associated with infant formula as a vehicle of transmission in many outbreaks in the world, such as in France (S. Agona, 2005), Korea (S. London, 2000), Spain (S. Virchow, 1994), Canada and the United States (S. Tennessee, 1993) [7-16]. One of the latest outbreaks occurred in France at the time of our study (S. Give, 2008) [17].

Outbreaks associated with commercial products like infant formula tend to have a low epidemic profile (small number of cases spread over long periods of time) because of the low bacterial load usually contained in the product [11]. However, continuous exposure to the factor for several months increases the probability of infection. The current Codex Alimentarius specification for Salmonella considers food products as fit for consumption when 60 samples of 25 gr are free from microorganisms [18]. Data provided by the infant food industry and inspection authorities indicate that Salmonella is rarely detected in powder infant products; nevertheless the microorganism can survive in powdered formula milk for up to 15 months and the method of detection can fail [19].

The increase in S. Kedougou isolations in Spain in 2008 was detected by the NCM because of the low expected frequency of this serotype in our country. This highlights the crucial role of the microbiology laboratories detecting outbreaks involving rare serotypes of microorganisms. Laboratory networks with a role in early detection of alert signals can complement surveillance systems in detecting uncommon microorganisms that otherwise might go unnoticed.

The higher attack rate in children under the age of one year, the identical PFGE pattern, the wide geographical distribution in Spain and the consumption of a particular brand of infant formula by the first cases identified lead to the hypothesis that the milk could be the vehicle of infection. Moreover, almost all cases older than one year could be explained by consumption of Brand A milk or by epidemiological link with younger cases.

In our study, most adult cases were probably secondary cases. Those cases for whom no contact with children under the age of one year could be established had consumed Brand A formula milk. By restricting our study to cases under one year of age we increased the specificity of the case definition because only primary cases were included. In case-control studies recall bias usually differs between cases and controls; parent cases tend to recall better than parent controls. In our study, we minimised this bias by restricting the analysis to cases under the age of one year, for whom food consumption patterns are usually constant and thus less prone to recall bias. However, some bias could be present given the delay between the interview and the onset of symptoms (mean: 108 days, range: 9-222 days).

The matched case-control study design chosen [20] included matching for medical practitioner as a way to facilitate the control search and selection. This could have lead to overexposure among controls because doctors could tend to recommend the same infant formula to their patients. Nevertheless this assumption was not confirmed by our data, as only few controls consumed the involved milk brand compared with 100% of the cases.

In the case-control questionnaires, up to five varieties of Brand A milk were reported, but the small number of exposed controls did not allow further analysis to identify a specific variety associated with the outbreak. Except in two cases, it was not possible to obtain details on the batch of formula milk consumed by the patients.

The number of cases confirmed at the laboratory (42 cases) might be an underrepresentation of the real number of infections since only a small proportion of people with gastroenteritis seeks medical assistance and provide a sample for laboratory testing. This might be also applicable for the age group at risk (under one year) because even when parents seek medical assistance for their children, gastrointestinal illness might be frequently misdiagnosed as milk/food intolerance as initially happened in two of the cases identified.

This is the first outbreak of S. Kedougou associated with the consumption of infant formula in Spain. The results of the investigation involving epidemiological services of all Spanish regions and the NCE support the hypothesis that the Brand A formula milk was the vehicle of the S. Kedougou gastroenteritis outbreak, occurring between February and August 2008.

The authors would like to thank all the professionals and institutions that made this study possible. We are grateful to Dr Camelia Savulescu for her useful comments about the article and to the members of the Spanish Field Epidemiology Training Programme (PEAC) for their guide and collaboration.


  1. Emberland KE, Nygard K, Heier BT, Aavitsland P, Lassen J, Stavnes TL et al. Outbreak of Salmonella Kedougou in Norway associated with salami, April-June 2006. Euro Surveill. 2006;11(27). pii=2993. Available from:
  2. Salmonella Kedougou and cooked meats. Commun Dis Rep CDR Wkly. 1992;2(35):159.
  3. Usera MA, Echeita A, Aladueña A, Blanco MC, Reymundo R, Prieto MI, et al. Interregional foodborne salmonellosis outbreak due to powdered infant formula contaminated with lactose-fermenting Salmonella virchow. Eur J Epidemiol. 1996;12(4):377-81.
  4. Usera MA, Rodriguez A, Echeita A, Cano R. Multiple analysis of a foodborne outbreak caused by infant formula contaminated by an atypical Salmonella virchow strain. Eur J Clin Microbiol Infect Dis. 1998;17(8):551-5.
  5. Investigation internationale: Belgique, France, Royaume-Uni et le réseau Salm-Net/International investigation: Belgium United Kingdom France and the Salm-Net network. Preliminary report of an international outbreak of Salmonella anatum infection linked to an infant formula milk. Euro Surveill. 1997;2(3). pii=190. Available from:
  6. Djuretic T. Salmonella java PT Worksop in young children associated with fortified milk. Euro Surveill. 1997;1(14). pii=1068. Available from:
  7. Cahill SM, Wachsmuth IK, Costarrica Mde L, Ben Embarek PK. Powdered infant formula as a source of Salmonella infection in infants. Clin Infect Dis. 2008;46(2):268-73.
  8. Rowe B, Begg NT, Hutchinson DN, Dawkins HC, Gilbert RJ, Jacob M, et al. Salmonella ealing infections associated with consumption of infant dried milk. Lancet. 1987;2(8564):900-3.
  9. Centers for Disease Control and Prevention (CDC). Salmonella serotype Tennessee in powdered milk products and infant formula — Canada and the United States, 1993. MMWR Morb Mortal Wkly Rep. 1993;42(26):516–7.
  10. Threlfall EJ, Ward LR, Hampton MD, Ridley AM, Rowe B, Roberts D, et al. Molecular fingerprinting defi nes a strain of Salmonella enterica serotype Anatum responsible for an international outbreak associated with formula-dried milk. Epidemiol Infect. 1998;121:289-93
  11. Park JK, Seok WS, Choi BJ, Kim HM, Lim BK, Yoon SS, et al. Salmonella enterica serovar London infections associated with consumption of infant formula. Yonsei Med J. 2004;45(1):43–8.
  12. Brouard C, Espié E, Weill FX, Kérouanton A, Brisabois A, Forgue AM, et al. Two consecutive large outbreaks of Salmonella enterica serotype Agona infections in infants linked to the consumption of powdered infant formula. Pediatr Infect Dis J. 2007;26(2):148–52.
  13. Organización de las Naciones Unidas para la Agricultura y la Alimentación. Organización Mundial de la Salud. Serie de evaluación de riesgos microbiológicos 6: Enterobacter sakazakii y otros microorganismos en los preparados en polvo para lactantes. Informe de la reunión. Roma, 2004. [Spanish]. Available from:
  14. Jourdan N, Le Hello S, Delmas G, Clouzeau J, Manteau C, Désaubliaux B, et al. Nationwide outbreak of Salmonella enterica serotype give infections in infants in France, linked to infant milk formula, September 2008. Euro Surveill. 2008;13(39). pii=18994. Available from:
  15. Comisión del Codex Alimentarius. Organización de las Naciones Unidas para la Agricultura y la alimentación y Organización Mundial de la Salud. 31 periodo de sesiones. Ginebra (Suiza) 30 de junio - 4 de julio de 2008. ALINORM 08/31/13. [Spanish].
  16. Barron JC, Forsythe SJ. Dry stress and survival time of Enterobacter sakazakii and other Enterobacteriaceae in dehydrated powdered infant formula. J Food Prot. 2007;70(9):2111-7.
  17. Rothman KJ, Greenland S. Modern epidemiology. 2nd edition. Philadelphia: Lippincott-Raven, 1998. Modern Epidemiology. 2nd ed. Kenneth J. Rothman and Sander Greenland. Lippincott-Raven, U.S.A., 1998.
  18. Mehta CR, Patel NR. Exact logistic regression: theory and examples. Stat Med. 1995;14(19):2143-60.
  19. Center for Disease Control and Prevention (CDC). Multistate outbreak of Salmonella infections associated with frozen pot pies – United States, 2007. MMWR Morb Mortal Wkly Rep. 2008;57(47):1277-80.
  20. Heinze G. A comparative investigation of methods for logistic regression with separated or nearly separated data. Stat Med. 2006;25(24):4216-26.
  21. Soler P, Herrera S, Rodríguez J, Cascante J, Cabral R, Echeita-Sarriondia A, et al. Nationwide outbreak of Salmonella enterica serotype Kedougou infection in infants linked to infant formula milk, Spain, 2008. Euro Surveill. 2008;13(35). pii=18963. Available from:
  22. World Health Organization in collaboration with Food and Agriculture Organization of the United Nations. Safe preparation, storage and handling of powdered infant formula: guidelines. World Health Organization 2007. Available from:

Back to Table of Contents
Previous Download (pdf)

The publisher’s policy on data collection and use of cookies.

Disclaimer: The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Eurosurveillance [ISSN] - ©2007-2016. All rights reserved

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.